Global Soft Tissue Repair Market 2017-2021

  • ID: 4143818
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • Avita Medical
  • Caladrius Biosciences
  • Holostem Terapie Avanzate
  • Neuralstem
  • Soft Tissue Regeneration
  • MORE
About Soft Tissue Repair

Soft tissue repair market consists of cell therapy-based products, tissue scaffolds, and soft tissue fixation devices and accessories. Cell therapy and tissue scaffold products are developed through bioengineering, which requires extensive funding to conduct R&D and clinical trials. Hence, support from the governments in developed countries will encourage various large and small companies to develop novel technology.

The analysts forecast the global soft tissue repair market to grow at a CAGR of 13.32% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global soft tissue repair market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Soft Tissue Repair Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Acelity
- Arthrex
- Ethicon
- Medtronic

Other prominent vendors
- ACE Surgical Supply
- AlloCure
- AlloSource
- Anterogen
- Antibe Therapeutics
- Athersys
- Avita Medical
- AxoGen
- Bacterin International
- Baxter
- Biogen
- BioRestorative Therapies
- Biostage
- BioTissue Technologies
- BrainStorm Cell Therapeutics
- Caladrius Biosciences
- Celgene
- Cell Therapy
- CONMED
- CRC for Cell Therapy Manufacturing
- Fibrocell Science
- Healthpoint
- Histogen
- Holostem Terapie Avanzate
- Integra Life Sciences
- ISTO Technologies
- Janssen Pharmaceutical
- K2M
- Mesoblast
- NeoStem
- Neuralstem
- Orteq
- Osiris Therapeutics
- Osteotech
- Orthofix International
- Parcus Medical
- Regenerys
- SanBio
- Soft Tissue Regeneration
- Stratatech
- Straumann
- Tissue Genesis
- Tornier
- Vericel
- ViaCyte
- XTANT Medical
Market drivers
- Rise in strategic partnerships for distribution of products.
- For a full, detailed list, view the full report

Market challenges
- High cost of clinical trials and failure rate in clinical trials.
- For a full, detailed list, view the full report

Market trends
- Gene therapy – An emerging trend in the market.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the Key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • Avita Medical
  • Caladrius Biosciences
  • Holostem Terapie Avanzate
  • Neuralstem
  • Soft Tissue Regeneration
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
  • Government funding and support encouraging soft tissue repair market
  • Focus to expand market presence by vendors
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Global cell therapy market
  • Global tissue scaffold market
  • Global soft tissue fixation devices and accessories
PART 07: Market segmentation by application
  • Neurology and orthopedic
  • Dermatology
  • Dental
  • Breast cancer
PART 08: Market segmentation by end-users
  • Hospitals and clinics
  • ASCs
  • Physicians' offices
PART 09: Geographical segmentation
  • Soft tissue repair market in Americas
  • Soft tissue repair market in EMEA
  • Soft tissue repair market in APAC
PART 10: Market drivers
  • Rising incidence of accidental injuries
  • Rise in strategic partnerships for distribution of products
  • Reimbursement for soft tissue repair products
PART 11: Impact of drivers

PART 12: Market challenges
  • High cost of clinical trials and failure rate in clinical trials
  • Complications associated with soft tissue repair products
  • Stringent regulatory impeding product approvals
  • Critical ethical challenges with respect to stem cell research
PART 13: Impact of drivers and challenges

PART 14: Market trends
  • Gene therapy – An emerging trend in the market
  • Increasing strategic alliances
  • Development of novel products
PART 15: Vendor landscape
  • Competitive landscape
PART 16: Key vendor analysis
  • Acelity
  • Arthrex
  • Ethicon
  • Medtronic
  • Key companies to watch
  • Other prominent vendors
PART 17: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Co-funding by government and other institutions for cell therapy-based research in US
Exhibit 02: Overview: Global soft tissue repair market by product
Exhibit 03: Global soft tissue repair market 2016-2021 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Ethical issues faced in different cell therapy research category
Exhibit 06: Stem cell research policies in emerging countries in Americas
Exhibit 07: Stem cell research policies in EMEA
Exhibit 08: Stem cell research policies in APAC
Exhibit 09: Key cell therapy products marketed in US
Exhibit 10: Key cell therapy products marketed in EMEA
Exhibit 11: Key cell therapy products marketed in APAC
Exhibit 12: Opportunity analysis of cell therapy in global soft tissue repair market
Exhibit 13: Global cell therapy market 2016-2021 ($ billions)
Exhibit 14: Types of tissue scaffolds
Exhibit 15: Strategic recommendation for companies based on collaboration in the industry
Exhibit 16: Opportunity analysis of tissue scaffold in global soft tissue repair market
Exhibit 17: Global tissue scaffold market 2016-2021 ($ billions)
Exhibit 18: Recent M&A in tissue scaffold market
Exhibit 19: Opportunity analysis of soft tissue fixation devices and accessories in global soft tissue repair market
Exhibit 20: Global soft tissue fixation devices and accessories market 2016-2021 ($ billions)
Exhibit 21: Global soft tissue repair market by application 2016
Exhibit 22: Market overview: Neurology and orthopedic
Exhibit 23: Market overview: Dermatology
Exhibit 24: Market overview: Dental
Exhibit 25: Market overview: Breast cancer
Exhibit 26: Global soft tissue repair market by end-users 2016
Exhibit 27: Global soft tissue repair market by geography in 2016 and 2021 ($ billions)
Exhibit 28: Market overview: Soft tissue repair market in Americas
Exhibit 29: Soft tissue repair market in Americas 2016-2021 ($ billions)

Exhibit 30: Market impact analysis: Soft tissue repair market in Americas
Exhibit 31: Market overview: Soft tissue repair market in US
Exhibit 32: PEST analysis: Soft tissue repair market in US
Exhibit 33: Market overview: Soft tissue repair market in EMEA
Exhibit 34: Hospital admissions of people with diabetes in EMEA in 2008 and 2013
Exhibit 35: Soft tissue repair market in EMEA 2016-2021 ($ billions)
Exhibit 36: Market impact analysis: Soft tissue repair market in EMEA
Exhibit 37: Market overview: Soft tissue repair market in UK
Exhibit 38: PEST analysis: Soft tissue repair market in UK
Exhibit 39: Market overview: Soft tissue repair market in APAC
Exhibit 40: Soft tissue repair market in APAC 2016-2021 ($ billions)
Exhibit 41: Market impact analysis: Soft tissue repair market in APAC
Exhibit 42: Market overview: Soft tissue repair market in Japan
Exhibit 43: PEST analysis: Soft tissue repair market in Japan
Exhibit 44: Number of road injuries in UK in 2015
Exhibit 45: Partnership for marketing soft tissue repair products
Exhibit 46: Reimbursement for soft tissue repair products in US
Exhibit 47: Impact of drivers
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Major strategic alliances in soft tissue repair market
Exhibit 50: Novel product in the soft tissue repair market
Exhibit 51: Competitive structure analysis of global soft tissue repair market 2016
Exhibit 52: Competitive landscape analysis of global soft tissue repair market 2016
Exhibit 53: Strategic recommendation for existing and new entrants in global soft tissue repair market
Exhibit 54: Acelity: Key highlights
Exhibit 55: Acelity: Strength assessment
Exhibit 56: Acelity: Strategy assessment
Exhibit 57: Acelity: Opportunity assessment
Exhibit 58: Arthrex: Key highlights
Exhibit 59: Arthrex: Strength assessment
Exhibit 60: Arthrex: Strategy assessment
Exhibit 61: Arthrex: Opportunity assessment
Exhibit 62: Ethicon: Key highlights
Exhibit 63: Ethicon: Strength assessment
Exhibit 64: Ethicon: Strategy assessment
Exhibit 65: Ethicon: Opportunity assessment
Exhibit 66: Medtronic: Key highlights
Exhibit 67: Medtronic: Strength assessment
Exhibit 68: Medtronic: Strategy assessment
Exhibit 69: Medtronic: Opportunity assessment
Exhibit 70: Key companies to watch
Exhibit 71: Global soft tissue repair market: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • Avita Medical
  • Caladrius Biosciences
  • Holostem Terapie Avanzate
  • Neuralstem
  • Soft Tissue Regeneration
  • MORE
New Report Released: – Global Soft Tissue Repair Market 2017-2021

The author of the report recognizes the following companies as the key players in the global soft tissue repair market: Acelity, Arthrex, Ethicon, and Medtronic.

Other Prominent Vendors in the market are: ACE Surgical Supply, AlloCure, AlloSource, Anterogen, Antibe Therapeutics, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Biogen, BioRestorative Therapies, Biostage, BioTissue Technologies, BrainStorm Cell Therapeutics, Caladrius Biosciences, Celgene, Cell Therapy, CONMED, CRC for Cell Therapy Manufacturing, Fibrocell Science, Healthpoint, Histogen, Holostem Terapie Avanzate, Integra Life Sciences, ISTO Technologies, Janssen Pharmaceutical, K2M, Mesoblast, NeoStem, Neuralstem, Orteq, Osiris Therapeutics, Osteotech, Orthofix International, Parcus Medical, Regenerys, SanBio, Soft Tissue Regeneration, Stratatech, Straumann, Tissue Genesis, Tornier, Vericel, ViaCyte, and XTANT Medical.

Commenting on the report, an analyst from the research team said: “One trend in market increasing strategic alliances. Major vendors are entering strategic alliances with other vendors for drug development and manufacturing. This trend is anticipated during the forecast period. Leading vendors in the market are undertaking M&A to strengthen their global position and to improve their commercial capabilities. Through increasing strategic alliances, many companies are receiving upfront and royalty payment, which encourages many small companies to involve into R&D and develop novel soft tissue repair products.

According to the report, one driver in market is rise in strategic partnerships for distribution of products. Vendors form strategic partnerships to expand their businesses, extend their product offerings, and increase their market shares. These partnerships also help companies to align their technologies with each other's innovative medical device portfolio. Through distribution partnerships, the small companies are expanding their presence in various geographical regions. This will help them to increase their market share globally, which will also provide intense competition to large vendors.

Further, the report states that one challenge in market is high cost of clinical trials and failure rate in clinical trials. Most vendors conduct clinical trials in developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea. As these are high-income countries, the cost of clinical trials and product launch in these countries will be high. Most of the small vendors or start-up biotech companies seek government or private funding, but most of the organizations provide limited amount of funding or grant to vendors if the targeted goal is completed. Estimated cost of soft tissue repair product such as cell therapy-based products from pre-clinical developmental stage to approval of product can cost up to $1.5 billion to the company.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Acelity
  • Arthrex
  • Ethicon
  • Medtronic
  • ACE Surgical Supply
  • AlloCure
  • AlloSource
  • Anterogen
  • Antibe Therapeutics
  • Athersys
  • Avita Medical
  • AxoGen
  • Bacterin International
  • Baxter
  • Biogen
  • BioRestorative Therapies
  • Biostage
  • BioTissue Technologies
  • BrainStorm Cell Therapeutics
  • Caladrius Biosciences
  • Celgene
  • Cell Therapy
  • CONMED
  • CRC for Cell Therapy Manufacturing
  • Fibrocell Science
  • Healthpoint
  • Histogen
  • Holostem Terapie Avanzate
  • Integra Life Sciences
  • ISTO Technologies
  • Janssen Pharmaceutical
  • K2M
  • Mesoblast
  • NeoStem
  • Neuralstem
  • Orteq
  • Osiris Therapeutics
  • Osteotech
  • Orthofix International
  • Parcus Medical
  • Regenerys
  • SanBio
  • Soft Tissue Regeneration
  • Stratatech
  • Straumann
  • Tissue Genesis
  • Tornier
  • Vericel
  • ViaCyte
  • XTANT Medical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll